Artificial intelligence across the drug-discovery pipeline
JAIDD publishes research on generative molecular design, protein structure prediction, ADMET modelling and other machine-learning methods across the drug-discovery pipeline, from target identification to lead optimisation.
Launch phase. The founding editorial board is being appointed. The journal will open for submissions once the board is in place. Articles accepted during the launch phase are published without an article processing charge. Information for authors
Scope
Generative DesignProtein Structure PredictionADMET PredictionRetrosynthesisTarget Identification
Checks before peer reviewWhat is checked before a manuscript is sent to reviewers.Editorial boardFounding board: appointments in progress.PublisherVallensis Publishing, Glis, Switzerland.
The journal publishes continuously: articles appear online as soon as they have been accepted and prepared, without issues or volumes.
